Cargando…

Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations

PURPOSE OF REVIEW: Analytical treatment interruption (ATI) remains an essential component in clinical studies investigating novel agents or combination treatment strategies aiming to induce HIV treatment-free remission or long-term viral control. We provide an overview on key study design aspects of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Lu, Tierney, Camlin, Bosch, Ronald J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	HIV Pathogenesis and Treatment (AL Landay and NS Utay, Section Editors)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251690/ https://www.ncbi.nlm.nih.gov/pubmed/34213731 http://dx.doi.org/10.1007/s11904-021-00569-8

Ejemplares similares

Defining T Cell Tissue Residency in Humans: Implications for HIV Pathogenesis and Vaccine Design
por: Shacklett, Barbara L., et al.
Publicado: (2020)

The Antibodiome—Mapping the Humoral Immune Response to HIV
por: Butler, Audrey L., et al.
Publicado: (2019)

Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework
por: Wedderburn, Catherine J., et al.
Publicado: (2019)

The Reproductive Transition: Effects on Viral Replication, Immune Activation, and Metabolism in Women with HIV infection
por: Abelman, Rebecca, et al.
Publicado: (2021)

Latency Reversal 2.0: Giving the Immune System a Seat at the Table
por: Singh, Vidisha, et al.
Publicado: (2021)

Microbiome Studies in Non-human Primates
por: Brenchley, Jason M., et al.
Publicado: (2021)

Practical Considerations in Gene Therapy for HIV Cure
por: Stan, Rodica, et al.
Publicado: (2014)

Sex Differences in HIV Infection
por: Scully, Eileen P.
Publicado: (2018)

The Role of Integrin α(4)β(7) in HIV Pathogenesis and Treatment
por: Arthos, James, et al.
Publicado: (2018)

Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System
por: Bhiman, Jinal N., et al.
Publicado: (2017)

Bioinformatics and HIV Latency
por: Ciuffi, Angela, et al.
Publicado: (2015)

NK Cells in HIV Disease
por: Scully, Eileen, et al.
Publicado: (2016)

Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Human Immunodeficiency Virus (HIV)-1 Integration Sites in Viral Latency
por: Rezaei, Simin D., et al.
Publicado: (2015)

How to Define the Latent Reservoir: Tools of the Trade
por: Barton, Kirston M., et al.
Publicado: (2016)

Using the Pathogenic and Nonpathogenic Nonhuman Primate Model for Studying Non-AIDS Comorbidities
por: Pandrea, Ivona, et al.
Publicado: (2015)

Sustained 10-year gain in adult life expectancy following antiretroviral therapy roll-out in rural Malawi: July 2005 to June 2014
por: Price, Alison J, et al.
Publicado: (2017)

HIV Treatment and Mental Health Outcomes Among Gay, Bisexual, and Other Men Who Have Sex With Men Living With HIV in a Pilot Multicomponent Intervention in Guatemala City
por: Barrington, Clare, et al.
Publicado: (2023)

Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example
por: Lai, Zhihong, et al.
Publicado: (2016)

Considerations in the Management of a Kidney Transplant Patient With HIV
por: Gilbert, James, et al.
Publicado: (2021)

Evaluating a community-based exercise intervention with adults living with HIV: protocol for an interrupted time series study
por: O'Brien, Kelly K, et al.
Publicado: (2016)

Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092
por: Owor, Maxensia, et al.
Publicado: (2021)

Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy
por: Muenchhoff, Maximilian, et al.
Publicado: (2018)

Restoring Cytokine Balance in HIV-Positive Individuals with Low CD4 T Cell Counts
por: Valdivia, Anddre, et al.
Publicado: (2017)

HIV and the eye
por: Gichuhi, Stephen, et al.
Publicado: (2020)

What Is the Best Preoperative Imaging for Endometrial Cancer?
por: Haldorsen, Ingfrid S., et al.
Publicado: (2016)

Prevention Strategies in Endometrial Carcinoma
por: MacKintosh, Michelle L., et al.
Publicado: (2018)

Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
por: Liu, Ying L., et al.
Publicado: (2018)

Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors
por: Wortman, Bastiaan G., et al.
Publicado: (2019)

What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?
por: Haldorsen, Ingfrid S., et al.
Publicado: (2019)

First-Line Management of Advanced High-Grade Serous Ovarian Cancer
por: Mahmood, Reem D., et al.
Publicado: (2020)

Pregnancy and Cancer: the INCIP Project
por: Maggen, Charlotte, et al.
Publicado: (2020)

Update on Histological Reporting Changes in Neuroendocrine Neoplasms
por: Bräutigam, Konstantin, et al.
Publicado: (2021)

The Role of Patient Support Groups in Neuroendocrine Neoplasms
por: Kolarova, Teodora, et al.
Publicado: (2021)

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy
por: Minczeles, N.S., et al.
Publicado: (2021)

New Directions in Imaging Neuroendocrine Neoplasms
por: Refardt, Julie, et al.
Publicado: (2021)

New Developments in Gastric Neuroendocrine Neoplasms
por: Exarchou, Klaire, et al.
Publicado: (2022)

Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?
por: Cope, Jack, et al.
Publicado: (2022)

How to Manage Small Intestine (Jejunal and Ileal) Neuroendocrine Neoplasms Presenting with Liver Metastases?
por: Niederle, Bruno, et al.
Publicado: (2021)

Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
por: Luchini, Claudio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6akkq5s33nk784hhgvldmbed7j